From 1960s counterculture guide to modern clinical wisdom: How a vintage LSD pamphlet is informing 21st-century psychedelic research

Lysergic acid diethylamide, commonly known as LSD, has undergone a profound transformation in public perception over the past six decades. Once a symbol of the volatile, anti-establishment counterculture of the 1960s, the compound is now at the center of a burgeoning clinical revolution. As contemporary researchers at institutions like Harvard University and the University of Buffalo begin to integrate psychedelics into modern therapeutic frameworks for depression, post-traumatic stress disorder (PTSD), and treatment-resistant anxiety, they are looking backward to find a foundation for safety and harm reduction. Surprisingly, the most effective guidance for today’s clinical trials may not be a high-tech discovery, but a modest, $1 pamphlet published in 1967 titled Session Games People Play: A Manual for the Use of LSD.

The Historical Context of Psychedelic Advocacy

In the mid-1960s, the American medical and social landscape was drastically different from today. Following the synthesis of LSD by Albert Hofmann in 1938 and its subsequent entry into the psychiatric community in the 1950s, the drug initially showed promise in treating alcoholism and neurosis. However, by the mid-60s, the substance had leaked into the mainstream, triggering a moral panic that eventually led to its classification as a Schedule I controlled substance in the United States.

Amidst this cultural upheaval, Lisa Bieberman, a young associate of Timothy Leary, recognized a growing void. While Leary championed the psychedelic experience as a revolutionary tool for societal transformation, his approach was often perceived as chaotic and reckless by those seeking a more measured experience. Bieberman, conversely, sought to provide practical, grounding advice to those experimenting with hallucinogens in informal settings. Her 1967 manual was designed to help users navigate the psychological intensity of a trip, warning against the "games"—or psychological pitfalls—that could turn an enlightening experience into a traumatic one.

The 2026 Clinical Validation Study

A recent study published in the academic journal Psychedelics has brought Bieberman’s work back into the light. Researchers, led by psychologist Daniel Kruger of the University of Buffalo, sought to determine if the intuitive wisdom offered in the 1967 pamphlet holds up under the scrutiny of modern psychological standards.

The research team conducted a comprehensive survey of nearly 600 self-professed users of various substances, including LSD, MDMA, psilocybin, and ketamine. The participants were asked to evaluate 19 specific pieces of advice taken directly from Bieberman’s manual. The results were striking: respondents expressed either strong or moderate agreement with 18 of the 19 points. This high level of consensus across diverse modern user groups suggests that the psychological challenges associated with the psychedelic experience are fundamentally consistent, regardless of the era in which they occur.

Key Principles of Safe Psychedelic Navigation

The "games" that Bieberman cautioned against in the 1960s remain central to the modern "set and setting" framework used in today’s clinical trials. Among the most endorsed pieces of advice in the recent survey were:

• Interpersonal Trust: Bieberman emphasized that one should only engage in a psychedelic session with people they trust implicitly. Modern researchers corroborate this, noting that the environment and the presence of "trip sitters" are critical variables in the patient’s psychological outcome.
• The Importance of Preparation: The manual advocated for extensive mental preparation prior to ingestion, a practice now standard in FDA-approved clinical trials involving psilocybin and MDMA.
• The Temporary Nature of the Experience: Reminding the user that the peak effects of the substance are transient helps to mitigate the anxiety that can arise during an intense session.
• Avoiding Public Excursions: Bieberman explicitly advised against using LSD in public or uncontrolled environments, a rule that remains a cornerstone of safety protocols to prevent sensory overload and social paranoia.

The only point of contention among the 600 survey participants was the advice to "avoid looking in the mirror." While some anecdotal reports suggest that seeing one’s own reflection can trigger body dysmorphia or dissociation during a trip, the survey data remained inconclusive, with respondents neither strongly agreeing nor disagreeing with the necessity of this precaution.

Implications for Public Health and Harm Reduction

The resurgence of interest in psychedelics has created a significant "knowledge gap." As states like Oregon and Colorado pioneer frameworks for legal, regulated, and therapeutic access to psychedelics, the public health sector is scrambling to provide education that prevents injury and psychological distress.

Dr. Daniel Kruger, speaking on the implications of his study, noted that the current legal environment is undergoing a rapid, albeit disjointed, evolution. "It’s a freight train coming down the tracks," Kruger said, emphasizing that the lack of standardized, accessible information for the public is a primary concern. He argues that by ignoring the necessity of harm reduction education, policymakers leave the public vulnerable to dangerous, unsupervised experimentation.

The study serves as a bridge between the grassroots harm reduction efforts of the 1960s and the formalized clinical protocols of the 2020s. By validating Bieberman’s work, researchers are essentially confirming that the fundamental principles of "set and setting"—a term popularized by Timothy Leary and Richard Alpert—are not merely relics of the hippie era but are empirically sound strategies for minimizing the risks associated with altered states of consciousness.

A Chronology of Psychedelic Integration

• 1938: Albert Hofmann synthesizes LSD at Sandoz Laboratories in Switzerland.
• 1950s: Early psychiatric research investigates LSD as a potential cure for alcoholism and various mood disorders.
• 1967: Lisa Bieberman publishes Session Games People Play, offering pragmatic advice for non-clinical users.
• 1970: The Controlled Substances Act is passed in the U.S., effectively ending most authorized psychedelic research for decades.
• 2000s–2010s: A "psychedelic renaissance" begins as researchers at Johns Hopkins, Imperial College London, and elsewhere receive approval to study psilocybin and LSD for end-of-life anxiety and depression.
• 2023–2024: Colorado and Oregon implement state-regulated access models for psilocybin, marking the first significant shift in U.S. policy in over 50 years.
• 2026: The study led by Daniel Kruger confirms that 1960s-era harm reduction advice remains highly relevant for modern users, prompting calls for its inclusion in public health education.

Analysis: The Future of Regulated Access

The integration of psychedelics into modern medicine is not without its challenges. Critics point to the risks of psychosis in predisposed individuals and the potential for long-term psychological dependence. However, the data gathered by the University of Buffalo suggests that when users are informed, prepared, and supported, the likelihood of a negative experience decreases significantly.

The "train station" analogy used by Dr. Kruger highlights the urgency of the situation. As public demand for alternative mental health treatments grows—driven by a perceived failure of traditional SSRI medications to treat treatment-resistant depression—the government is being pushed to fast-track regulatory pathways. The inclusion of vintage wisdom, like that of Bieberman, provides a cost-effective, time-tested framework that can be easily disseminated to the public.

For policy makers, the lesson is clear: if the public is going to seek out these substances regardless of legal status, the most responsible path is to provide the best possible information. The 1967 manual, once a fringe guide for counterculture enthusiasts, is now being recognized as a vital precursor to the standardized, evidence-based practices that will define the next chapter of psychiatric care. By bridging the gap between historical experience and modern clinical rigor, researchers hope to ensure that as society moves toward a more open relationship with psychedelics, it does so with safety and science at the forefront.